Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Ascendis Pharma Director Lars Holtug Sells 236 Shares

A Form 4 filed with the SEC on September 3, 2026, reports that Lars Holtug, a director of Ascendis Pharma A/S (NASDAQ:ASND), sold 236 ordinary shares on September 2, 2026.

Shwetambri Chauhan | 03 September 2026

Post Holdings Chairman Emeritus Sells Shares Held by Spouse

William P. Stiritz, Chairman Emeritus of Post Holdings, Inc., filed a Form 4 on September 3, 2026, disclosing the sale of 384,132 shares of common stock indirectly held by his spouse across two trading days, September 1 and September 2, 2026.

Aditi Sarkar | 03 September 2026

Generate Biomedicines Director Sells 1,000 Shares

Director Frances Arnold filed a Form 4 with the SEC on September 3, 2026, disclosing the sale of 1,000 shares of Generate Biomedicines, Inc. common stock on September 1, 2026, under a pre-established Rule 10b5-1 trading plan.

Manish Choudhary | 03 September 2026

DoorDash CFO Ravi Sells Shares Under 10b5-1 Plan

Ravi Inukonda, Chief Financial Officer of DoorDash, Inc. (NASDAQ:DASH), filed a Form 4 on September 3, 2026, disclosing the exercise of a stock option and the sale of Class A Common Stock on September 1, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Shwetambri Chauhan | 03 September 2026

DoorDash CEO Tony Xu Sells 16,667 Shares Under 10b5-1 Plan

DoorDash, Inc. (NASDAQ:DASH) Chief Executive Officer Tony Xu filed a Form 4 on September 3, 2026, disclosing transactions in Class A Common Stock dated September 1, 2026, including a stock option exercise and a same-day sale under a pre-established Rule 10b5-1 trading plan.

Manish Choudhary | 03 September 2026

Moderna Chief Legal Officer Files Form 4 Stock Activity Report

Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc. (NASDAQ:MRNA), reported multiple transactions in Moderna common stock and derivative securities on September 1, 2026, in a Form 4 filed with the SEC on September 3, 2026.

Aakashdeep | 03 September 2026

DoorDash Director Andy Fang Sells Class A Shares

A Form 4 filed on September 3, 2026 with the SEC reports that Andy Fang, a director of DoorDash, Inc. (NASDAQ:DASH), disposed of 15,000 shares of Class A Common Stock on September 1, 2026 under a pre-established Rule 10b5-1 trading plan.

Aditi Sarkar | 03 September 2026

Moderna President Stephen Hoge RSU Vest and Tax Withholding

Moderna, Inc. (NASDAQ:MRNA) President Stephen Hoge filed a Form 4 on September 3, 2026, disclosing the vesting of restricted stock units and a related tax-withholding share disposition dated September 1, 2026.

Shwetambri Chauhan | 03 September 2026

Moderna CFO James Mock Reports RSU Vest and Share Withholding

A Form 4 filed on September 3, 2026, with the U.S. Securities and Exchange Commission discloses two transactions in Moderna, Inc. common stock by Chief Financial Officer James M. Mock on September 1, 2026.

Shwetambri Chauhan | 03 September 2026

Veracyte Director Sells 1,864 Shares Under 10b5-1 Plan

A Form 4 filed on September 3, 2026 disclosed that Muna Bhanji, a director of Veracyte, Inc. (NASDAQ:VCYT), sold 1,864 shares of common stock on September 1, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 03 September 2026
Support

Hi! How can we help you today?

Loading…